Karakterisasi Metabolit Bioaktif Pare (Momordica charantia) sebagai Pengontrol Gula Darah dan Pendukung Pencernaan

Lisa Fitriana; Ardi Mustakim

doi:10.55606/detector.v4i1.5831

Authors

Lisa Fitriana Universitas Adiwangsa Jambi
Ardi Mustakim Universitas Adiwangsa Jambi

DOI:

https://doi.org/10.55606/detector.v4i1.5831

Keywords:

Bitter Melon, Bioactive Metabolites, Blood Glucose, Digestion, Momordica Charantia

Abstract

Bitter melon (Momordica charantia) is a medicinal plant traditionally used to control blood glucose levels and improve digestive health. These benefits are closely associated with its bioactive metabolite content. This article aims to characterize the bioactive metabolites of bitter melon and to review their potential bioactivity in glycemic control and digestive function. The method employed includes a literature-based characterization of metabolites, identification of major classes of active compounds, and evaluation of analytical techniques commonly applied in natural product research, such as phytochemical screening, chromatography, and spectroscopic analysis. The results indicate that bitter melon contains various bioactive metabolites, including flavonoids, alkaloids, saponins, triterpenoids, and polyphenols, which contribute to blood glucose reduction by enhancing insulin sensitivity and inhibiting glucose absorption. Furthermore, these compounds support digestive health by improving digestive enzyme activity, exhibiting anti-inflammatory effects, and maintaining gut microbial balance. In conclusion, bitter melon represents a promising source of natural bioactive compounds with significant potential for application in health and pharmaceutical development.

Downloads

Download data is not yet available.

References

Ahmad, Z., Zamhuri, K. F., Yaacob, A., Siong, C. H., Selvarajah, M., Ismail, A., & Hakim, M. N. (2012). In vitro anti-inflammatory activities of extracts of Momordica charantia. Journal of Medicinal Plants Research, 6(23), 3971–3976. https://doi.org/10.5897/JMPR11.1550

Ahmed, I., Adeghate, E., Sharma, A. K., Pallot, D. J., & Singh, J. (1998). Effects of Momordica charantia fruit juice on islet morphology in the pancreas of the streptozotocin-diabetic rat. Diabetes Research and Clinical Practice, 40(3), 145–151.

Akhtar, N., Khan, B. A., Haji, M., Khan, S., Ahmad, M., & Rasool, F. (2011). Evaluation of antidiabetic activity of Momordica charantia fruit in experimental animal models. Journal of Medicinal Plants Research, 5(1), 51–56.

Chaturvedi, P. (2012). Antidiabetic potentials of Momordica charantia: Multiple mechanisms behind the effects. Journal of Medicinal Food, 15(2), 101–107.

Grover, J. K., & Yadav, S. P. (2004). Pharmacological actions and potential uses of Momordica charantia: A review. Journal of Ethnopharmacology, 93(1), 123–132. https://doi.org/10.1016/j.jep.2004.03.035

Jia, S., Shen, M., Zhang, F., & Xie, J. (2017). Recent advances in Momordica charantia: Functional components and biological activities. International Journal of Molecular Sciences, 18(12), 2555. https://doi.org/10.3390/ijms18122555

Joseph, B., & Jini, D. (2013). Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal potency. Asian Pacific Journal of Tropical Disease, 3(2), 93–102. https://doi.org/10.1016/S2222-1808(13)60052-3

Kumar, D. S., Sharathnath, K. V., Yogeswaran, P., Harani, A., Sudhakar, K., Sudha, P., & Banji, D. (2010). A medicinal potency of Momordica charantia. International Journal of Pharmaceutical Sciences Review and Research, 1(2), 95–100.

Mahomoodally, M. F., Mootoosamy, A., & Wambugu, S. N. (2017). Traditional medicinal plants used to manage digestive disorders. Journal of Ethnopharmacology, 202, 145–162.

Matsui, T., Ogunwande, I. A., Abesundara, K. J. M., & Matsumoto, K. (2003). Anti-hyperglycemic potential of natural products. Journal of Nutritional Science and Vitaminology, 49(2), 81–87.

Nerurkar, P. V., Lee, Y. K., & Nerurkar, V. R. (2010). Momordica charantia (bitter melon) inhibits primary human adipocyte differentiation by modulating adipogenic genes. BMC Complementary and Alternative Medicine, 10, 34. https://doi.org/10.1186/1472-6882-10-34

Nerurkar, P. V., Lee, Y. K., Linden, E. H., Lim, S., Pearson, L., Frank, J., & Nerurkar, V. R. (2006). Lipid-lowering and metabolic effects of Momordica charantia in cellular experimental models. Phytotherapy Research, 20(10), 865–870.

Nerurkar, P. V., Pearson, L., Efird, J. T., Adeli, K., Theriault, A. G., & Nerurkar, V. R. (2008). Microsomal triglyceride transfer protein gene expression and lipid profiles. British Journal of Nutrition, 99(2), 235–243.

Patel, S., Patel, T., Parmar, K., Bhatt, Y., Patel, Y., & Patel, N. M. (2016). Isolation, characterization and antimicrobial activity of charantin from Momordica charantia. Journal of Pharmacognosy and Phytochemistry, 5(2), 171–175.

Shih, C. C., Lin, C. H., & Wu, J. B. (2009). Efficacy of Momordica charantia extract on insulin resistance and glucose metabolism in type 2 diabetic mice. Phytotherapy Research, 23(9), 1187–1193.

Singh, N., Gupta, M., & Sirohi, P. (2014). Effects of alcoholic extract of Momordica charantia on lipid profile, oxidative stress, and glycemic control in diabetic rats. Journal of Diabetes & Metabolic Disorders, 13(1), 1–8.

Sur, P., Chaudhuri, T., Vedasiromoni, J. R., Gomes, A., & Ganguly, D. K. (2000). Antiinflammatory and antioxidant property of saponins of Momordica charantia. Phytotherapy Research, 14(6), 445–447.

World Health Organization. (2002). WHO traditional medicine strategy 2002–2005. World Health Organization.

Wu, S. J., & Ng, L. T. (2008). Antioxidant and free radical scavenging activities of wild bitter melon (Momordica charantia Linn. var. abbreviata Ser.). Food Chemistry, 109(4), 775–783.

Wu, X., Li, M., & Xu, C. (2014). Protective effects of bitter melon on gastrointestinal inflammation. Journal of Medicinal Food, 17(9), 1051–1058.

Xu, X., Shan, B., & Liu, L. (2015). Phenolic compounds and anti-inflammatory activity of bitter melon. Food Chemistry, 173, 913–921.